This article is from the WebMD News Archive
Cosmetic Surgery Up in U.S.
March 16, 2006 -- Cosmetic surgery continues to rise in the U.S. In 2005, cosmetic procedures -- including surgery and minimally invasive treatments such as Botox injections and laser hair removal -- were done more than 10 million times in the U.S.
That's an increase of 11% from 2004 and 38% from 2000, according to the American Society of Plastic Surgeons. Add in reconstructive plastic surgery -- such as surgery to remove tumors or mend wounds -- and the grand total tops 15 million procedures.
Most cosmetic patients were women, whites, and middle-aged adults, the report shows. But more than a million men got cosmetic procedures. So did more than 300,000 youths aged 18 and younger.
Most Common Cosmetic Surgeries
According to the report, America's five most common cosmetic surgeries in 2005 were:
- Liposuction: 323,605
- Nose reshaping: 298,413
- Breast augmentation: 291,350
- Eyelid surgery: 230,697
- Tummy tuck: 134,746
Facelifts didn't make the list.
"The facelift is still a highly sought-after procedure. Nearly 109,000 were performed last year," says American Society of Plastic Surgeons president Bruce Cunningham, MD, in a news release.
"However, the fact [that] it didn't make the top five surgical procedures can be attributed to increased consumer demand for minimally invasive injectable wrinkle fillers and fighters as a remedy to combat facial aging," Cunningham says.
Other Procedures
The report also lists the top five minimally invasive cosmetic procedures:
- Botox: 3,839,387
- Chemical peel: 1,033,581
- Microdermabrasion: 837,711
- Laser hair removal: 782,732
- Sclerotherapy (includes injectable wrinkle fillers): 589,768
The most common reconstructive surgeries were:
- Tumor removal: 3,936,405
- Laceration (cut) repair: 344,231
- Scar revision: 181,011
- Hand surgery: 171,972
- Breast reduction: 114,250
Data came from a national online database for plastic surgery procedures and from an annual survey sent to more than 17,000 board-certified specialists in specialties most likely to perform plastic surgery.
Different Groups, Different Data
The three most commonly requested cosmetic surgeries varied by ethnic group:
- Blacks: Nose reshaping, liposuction, and breast reduction
- Asian Americans: Nose reshaping, eyelid surgery, and breast augmentation
- Hispanics: Breast augmentation, liposuction, and nose reshaping
The most common cosmetic surgeries for men were nose reshaping, hair transplantation, liposuction, eyelid surgery, and breast reduction. More than 300,000 men got Botox and more than 200,000 got micodermabrasion, the report shows.
For the youngest patients, who were at most 18 years old, nose reshaping led the list. More than 47,300 youths had their noses reshaped in 2005, compared with more than 13,000 who got cosmetic surgery on their ears, about 3,000 who got liposuction, about 3,500 who got breast augmentation, and about 4,200 males who had breast reduction surgery.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


